|
|
Post by johank on Mar 19, 2015 14:43:44 GMT
This company just had good P2a safety results from its trial for treatment of Alzheimer's. Anyone following this company? What do you think? I'm thinking about taking a position. The drug, bryostatin, was previously tested for cancer treatment and they are building upon the data from that trial to treat AD. |
|
|
|
Post by Yelk on Mar 19, 2015 14:50:28 GMT
I've read some good articles on it, however spread too thin right now and need to dive into it. Longer away catalysts>?
|
|
|
|
Post by JHam on Mar 19, 2015 15:09:39 GMT
This company just had good P2a safety results from its trial for treatment of Alzheimer's. Anyone following this company? What do you think? I'm thinking about taking a position. The drug, bryostatin, was previously tested for cancer treatment and they are building upon the data from that trial to treat AD. I know nothing about this company but just took a quick look at the prospectus filed last month and think I'll stay away for now. www.sec.gov/Archives/edgar/data/1513856/000114420415008454/v401365_424b3.htmVery little cash and lots of murkiness on the future concerning when/how they will raise more: Capital Needs
With the capital raised to date as described above we had a cash and cash equivalent position of approximately $10.1 million as of September 30, 2014. We believe we had funding, as of December 1, 2014, for approximately the next 12 months based upon our current product development plans. However, as described in this prospectus, we are currently reviewing our strategic plans. We intend to adjust our operating plans, if necessary, by rationalizing non-contractual variable overhead expenses so that we have cash for operations through the end of the year ending December 31, 2015. In addition, we may choose to further reevaluate our strategic plan in the future. There can be no assurance that our current funding will last even through December 31, 2015. We will need to raise additional funds based upon advancing certain product development programs in our current and future pipeline. We will determine when and if to proceed with future fund raising efforts from time-to-time. There can be no assurance financing will be available to us when required on acceptable terms or at all.
cont'd
About This Offering
This prospectus relates to the public offering, which is not being underwritten, by the selling stockholders listed in this prospectus, of up to 25,225,000 shares of our common stock. Of the shares being offered, (a) 3,017,387 are issued and outstanding as of the date of this prospectus; (b) 20,708,194 of the shares of our common stock are issuable upon conversion of 20,708,194 outstanding shares of our Series A Stock, and (c) 1,499,419 of the shares of our common stock are issuable upon exercise of common stock purchase warrants. The shares offered by this prospectus may be sold by the selling stockholders from time to time in the open market, through negotiated transactions or otherwise at market prices prevailing at the time of sale or at negotiated prices. We will receive none of the proceeds from the sale of the shares by the selling stockholders. We will bear all expenses of registration incurred in connection with this offering, but all selling and other expenses incurred by the selling stockholders will be borne by them. |
|
|
|
Post by johank on Mar 19, 2015 16:06:42 GMT
Thanks! Yes, like other developing companies with no revenue, they definitely have some uncertainties looming about raising capital.
|
|
madamemagoo
Junior Member
don't shoot mandy magoo!
Posts: 70 
|
Post by madamemagoo on Mar 19, 2015 16:39:55 GMT
I own a small amount...just keeping an eye on it. I'd avoid it for now.
|
|
madamemagoo
Junior Member
don't shoot mandy magoo!
Posts: 70
|
Post by madamemagoo on Mar 20, 2015 13:57:22 GMT
Of course since I said to avoid it..,.it's gone up about 10%!  |
|
|
|
Post by JHam on Mar 20, 2015 15:23:42 GMT
Of course since I said to avoid it..,.it's gone up about 10%! That's the last time I listen to you! Kidding  Congrats on the nice bump! |
|
madamemagoo
Junior Member
don't shoot mandy magoo!
Posts: 70
|
Post by madamemagoo on Mar 21, 2015 12:23:18 GMT
And down again |
|
madamemagoo
Junior Member
don't shoot mandy magoo!
Posts: 70
|
Post by madamemagoo on Mar 30, 2015 19:37:11 GMT
|
|
|
|
Post by johank on Jan 13, 2017 0:22:08 GMT
This one popped back on my radar. Anyone else looking at this company recently? -completed a private raise of about $24M back in November -completed a reverse spilt -TL data from n=150 P2 due April '17 -plan to uplist to Nasdaq thereafter
Recently Eli Lilly failed their P3 for solanezumab in Altzheimer's taking a big player out of the picture.
|
|
Congrats on the nice bump!